Hitoshi Okada
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 10
- Cell death mechanisms and regulation 7
- Histone Deacetylase Inhibitors Research 5
- Immunology top 5%
- Neurology top 2%
- Oncology top 2%
- Cancer-related Molecular Pathways 5
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 4
-
- Blockchain Technology Applications and Security 5
-
- Sleep and Wakefulness Research 5
-
- Acute Myeloid Leukemia Research 4
- Co-authors
- Tak W. MakAndrew WakehamGordon S. DuncanAndrew EliaTetsuo NodaShigeru KatamineWoong‐Kyung SuhSumitaka Hasegawa
- Cited by
- Molecular BiologyImmunologyNeurology
- Journals
- Proceedings of the National Academy of Sciences (5 papers)Molecular and Cellular Biology (5 papers)The Journal of Cell Biology (3 papers)
- Partner nations
- JapanCanadaUnited States
In The Last Decade
Hitoshi Okada
104 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Molecular Biology 3.4k
- Immunology 895
- Neurology 338
- Oncology 1.0k
- Cancer Research 537
Countries citing papers authored by Hitoshi Okada
This map shows the geographic impact of Hitoshi Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Okada more than expected).
Fields of papers citing papers by Hitoshi Okada
This network shows the impact of papers produced by Hitoshi Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Okada. The network helps show where Hitoshi Okada may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hitoshi Okada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 7 | |
| 4 | 2021 | 27 | |
| 5 | 2020 | 41 | |
| 6 | 2019 | 2 | |
| 7 | A review of blockchain technology applications for academic institutions | 2017 | 2 |
| 8 | Solving the Difficult Problem of Topic Extraction in Thai Tweets | 2016 | 1 |
| 9 | 2007 | 106 | |
| 10 | 2006 | 46 | |
| 11 | 2005 | 42 | |
| 12 | 2005 | 213 | |
| 13 | 2004 | 315 | |
| 14 | 2004 | 47 | |
| 15 | Compound disruption of smad2 accelerates malignant progression of intestinal tumors in apc knockout mice. | 2002 | 62 |
| 16 | 2000 | 56 | |
| 17 | 1996 | 1 | |
| 18 | Acoustic Properties of Infant Cries and Maternal Perception | 1986 | 6 |
| 19 | 1985 | 4 | |
| 20 | Initial and Terminal Pitch of Uni-Directionaly Frequency Modulated Tones | 1985 | 1 |
About Hitoshi Okada
Hitoshi Okada is a scholar working on Aging, Structural Biology, Molecular Biology, Pharmacy and Cancer Research, having authored 107 papers that have together received 5.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (10 papers), Cell death mechanisms and regulation (7 papers), Histone Deacetylase Inhibitors Research (5 papers), Cancer-related Molecular Pathways (5 papers), Blockchain Technology Applications and Security (5 papers), Sleep and Wakefulness Research (5 papers), Protease and Inhibitor Mechanisms (4 papers) and Acute Myeloid Leukemia Research (4 papers). The work is most often cited by research in Molecular Biology (3.4k citations), Immunology (895 citations), Neurology (338 citations), Oncology (1.0k citations) and Cancer Research (537 citations). Hitoshi Okada has collaborated with scholars based in Japan, Canada and United States. Frequent co-authors include Tak W. Mak, Andrew Wakeham, Gordon S. Duncan, Andrew Elia, Tetsuo Noda, Tak W. Mak, Shigeru Katamine, Woong‐Kyung Suh, Sumitaka Hasegawa and Scott W. Lowe. Their work appears in journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology, The Journal of Cell Biology, Cell Death and Disease and Microscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.